Who We Are

Immfinity Biotechnologies was founded by Dr. Govinda Sharma, whose doctoral and post-doctoral research at the BC Cancer Agency —conducted in collaboration with immunogenetics pioneer Dr. Robert A. Holt—formed the basis of our proprietary discovery platform.

During this work, Dr. Sharma and his team developed high-throughput, next-generation screening technologies that accelerate T-cell antigen discovery and finely map immune interactions with unprecedented precision. These innovations now underpin new therapeutic opportunities in immuno-oncology and other immune-driven diseases.

At Immfinity, we leverage this cutting-edge science to engineer smarter, safer and more effective immune-based solutions for complex disease. Our mission is to transform cutting-edge immunology into real-world impact for patients.

BC Cancer Agency facade, which is a multi-story building with large circular windows, trees in foreground, some cars on the street.

Leadership Team

  • A man with dark hair and a beard smiling at the camera, wearing a white shirt, against a plain gray background.

    Govinda Sharma, PhD

    Founder, CEO

  • A smiling man with glasses and short dark hair, wearing a white t-shirt and a light blue jacket, standing against a plain background.

    Fei Teng, PhD

    Head of Research

  • A portrait of a man with glasses, a beard, wearing a black and white plaid shirt, smiling against a dark background.

    Kaan Biron, PhD

    Head of Operations

Advisors

  • A man with glasses, short brown hair, wearing a dark blazer and black shirt, standing against a gray background.

    Robert Holt, PhD

    Scientific Advisor